Mitsuhama just recently announced a new vaccine to protect against a common VITAS strain. This announcement comes hot on the tails Doc Wagons own announcement about a similar vaccine. Unfortunately, Doc Wagon has announced that their own product has to be delayed indefinitely. Doc Wagon refused to offer any more comment on the issue. While Doc Wagon’s announcement has been devastating to their stock value which dropped a full 3 points on the heels of Mitsuhama’s release, for Mitsuhama this has been a coup.
Well, this one’s pretty obviously a straightforward run. Get the data, sell it to another company.
–NetCat
Takes more than data to synthesize a vaccine. Takes talent as well.
–SnowGuard
Fair point.
–NetCat